Autophagy sensitivity of neuroendocrine lung tumor cells

International Journal of Oncology

Volumn 43, Issue 6, 2013, Pages 2031-2038

  Hong, Seung Keun ^a   Kim, Jin Hwan ^a   Starenki, Dmytro ^a   Park, Jong In ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

AKT; Autophagy; mTOR; Neuroendocrine lung cancer

Indexed keywords

BAFILOMYCIN A1; CHLOROQUINE; MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN 1; NEURON SPECIFIC ENOLASE; PROTEIN KINASE B; PROTEIN LC 3; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CANCER SURVIVAL; CARCINOID; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG SMALL CELL CANCER; LUNG TUMOR; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIMALARIALS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHLOROQUINE; ENZYME INHIBITORS; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; LUNG NEOPLASMS; MACROLIDES; MICROTUBULE-ASSOCIATED PROTEINS; NAPHTHYRIDINES; NEUROENDOCRINE TUMORS; PHOSPHOPYRUVATE HYDRATASE; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIROLIMUS; SMALL CELL LUNG CARCINOMA; TOR SERINE-THREONINE KINASES;

EID: 84891910915     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2136     Document Type: Article

References (36)

1. Siegel R, DeSantis C, Virgo K, et al: Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62: 220-241, 2012.
2. Herbst RS, Heymach JV and Lippman SM: Lung cancer. N Engl J Med 359: 1367-1380, 2008.
3. O'Byrne KJ, Gatzemeier U, Bondarenko I, et al: Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study. Lancet Oncol 12: 795-805, 2011.
4. Pietanza MC and Rudin CM: Novel therapeutic approaches for small cell lung cancer: the future has arrived. Curr Probl Cancer 36: 156-173, 2012.
5. Travis WD: Advances in neuroendocrine lung tumors. Ann Oncol 21 (Suppl 7): vii65-vii71, 2010.
6. Swarts DR, Ramaekers FC and Speel EJ: Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Biochim Biophys Acta 1826: 255-271, 2012.
7. Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell 132: 27-42, 2008.
8. Mathew R and White E: Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin Genet Dev 21: 113-119, 2011.
9. Mizushima N and Komatsu M: Autophagy: renovation of cells and tissues. Cell 147: 728-741, 2011.
10. Klionsky DJ, Codogno P, Cuervo AM, et al: A comprehensive glossary of autophagy-related molecules and processes. Autophagy 6: 438-448, 2010.
11. Tanida I, Ueno T and Kominami E: LC3 and autophagy. Methods Mol Biol 445: 77-88, 2008.
12. Chen ZH, Kim HP, Sciurba FC, et al: Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One 3: e3316, 2008.
13. Lahm T and Petrache I: LC3 as a potential therapeutic target in hypoxia-induced pulmonary hypertension. Autophagy 8: 1146-1147, 2012.
14. Righi L, Volante M, Rapa I, Scagliotti GV and Papotti M: Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data. Virchows Arch 451 (Suppl 1): S51-S59, 2007.
15. Taneja TK and Sharma S: Markers of small cell lung cancer. World J Surg Oncol 2: 10, 2004.
16. Lum JJ, DeBerardinis RJ and Thompson CB: Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol 6: 439-448, 2005.
17. Maiuri MC, Tasdemir E, Criollo A, et al: Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 16: 87-93, 2009.
18. Sarbassov DD, Guertin DA, Ali SM and Sabatini DM: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101, 2005.
19. Mostoslavsky G, Fabian AJ, Rooney S, Alt FW and Mulligan RC: Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci USA 103: 16406-16411, 2006.
20. Rubinson DA, Dillon CP, Kwiatkowski AV, et al: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33: 401-406, 2003.
21. Vindelov LL, Christensen IJ and Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983.
22. Hong SK, Yoon S, Moelling C, Arthan D and Park JI: Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling. J Biol Chem 284: 33006-33018, 2009.
23. Phelps RM, Johnson BE, Ihde DC, et al: NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem (Suppl 24): 32-91, 1996.
24. Hers I, Vincent EE and Tavare JM: Akt signalling in health and disease. Cell Signal 23: 1515-1527, 2011.
25. Dazert E and Hall MN: mTOR signaling in disease. Curr Opin Cell Biol 23: 744-755, 2011.
26. Thoreen CC, Kang SA, Chang JW, et al: An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284: 8023-8032, 2009.
27. Laplante M and Sabatini DM: mTOR signaling in growth control and disease. Cell 149: 274-293, 2012.
28. Potter CJ, Pedraza LG and Xu T: Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4: 658-665, 2002.
29. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ and Kim DH: Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9: 316-323, 2007.
30. Ryter SW and Choi AM: Autophagy in the lung. Proc Am Thorac Soc 7: 13-21, 2010.
31. Eckardt JR, von Pawel J, Pujol JL, et al: Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. J Clin Oncol 25: 2086-2092, 2007.
32. O'Brien ME, Ciuleanu TE, Tsekov H, et al: Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol 24: 5441-5447, 2006.
33. Merrill RM, Henson DE and Barnes M: Conditional survival among patients with carcinoma of the lung. Chest 116: 697-703, 1999.
34. Maes H, Rubio N, Garg AD and Agostinis P: Autophagy: shaping the tumor microenvironment and therapeutic response. Trends Mol Med 19: 428-446, 2013.
35. Pujol JL, Quantin X, Jacot W, Boher JM, Grenier J and Lamy PJ: Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer 39: 131-138, 2003.
36. Giovanella L, Piantanida R, Ceriani L, et al: Immunoassay of neuron-specific enolase (NSE) and serum fragments of cytokeratin 19 (CYFRA 21.1) as tumor markers in small cell lung cancer: clinical evaluation and biological hypothesis. Int J Biol Markers 12: 22-26, 1997.